Hormones and Hair Loss: The Medical Management of Androgenetic Alopecia in the Presence of Androgen Replacement Therapy - Single Course

1.0 CME CREDITS – $75.00

Hereditary hair loss or Androgenetic Alopecia affects approximately 40 million men in the United States. In 2017 it was estimated that 2.3 million American men receive testosterone replacement therapy. Numerous clinical trials have supported and confirmed that the progression of hair loss is an often-unwanted sign of aging and a significant trigger for decreased Quality of Life in the affected population. In men, the chronic progressive miniaturization of hair follicles and hair loss in response to an inherited sensitivity to endogenous, normal levels of dihydrotestosterone (DHT) can begin to occur soon after puberty, and eventually affecting more than half of all men by the time they age to 50. Because DHT, the primary trigger for androgenetic alopecia, is created from testosterone through the 5-alpha reductase pathway, actions/activities and treatments that are designed to beneficially replace or enhance testosterone levels are often associated with accelerated hereditary hair loss as DHT levels rise. Unwanted, unexpected and accelerated hair loss may be a barrier for continued androgen replacement therapy, resulting in patient’s cessation of therapy. An understanding of the stratagems used to elucidate risk factors, diagnose, measure/monitor signs and symptoms, as well as the initiation of therapeutic interventions for Androgenetic Alopecia, can be used to avoid and-or manage this increasingly common unintended and unwanted consequence of androgen replacement therapy and ensure continued patient compliance with their androgen replacement therapy regimen.

CME

Satisfactory Completion

Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, and complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available.  If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Continuing Education Language

Physicians

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Age Management Medicine Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this enduring material for a maximum of 8.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives – After attending this program you should be able to:

  1. Learn and understand the evidence-based theory of Interventional Endocrinology and the science behind and clinical applications of hormone therapy for patients who have been property assessed and diagnosed as deficient.
  2. Learn and understand the science and protocols in properly assessing patients who may have a hormone deficiency.
  3. Learn and understand the latest evidence-based research in the field of hormones and hormone replacement.
  4. Learn and understand the latest evidence-based Literature and Clinical Information on Estrogen Dominance.
  5. Learn and understand the signs and symptoms of adrenal fatigue & suboptimal thyroid and understand how to diagnose oververt endocrine disorders of the adrenal and thyroid.
  6. Learn and understand the signs of “estrogen dominance/progesterone deficiency,” when and how to measure levels, and the benefits of various delivery systems
  7. Learn and understand the latest evidence-based benefits and risks of bio-identical HRT and understand clinically based techniques to make this HRT more reliable and more successful.
  8. Learn and understand the latest evidence-based stratagems used to elucidate risk factors, diagnose, measure/monitor signs and symptoms, as well understanding therapeutic interventions for Androgenetic Alopecia.
  9. Learn and understand essentials of an Age Management BHRT program.


Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no relevant financial relationships.

First Name Last Name CI Relationship
Neal Rouzier Evexias Speakers Bureau
William Clearfield TrueMD Other
Alan Bauman Designs for Health Speakers Bureau

 

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Release Date: September 15, 2019
Expiration Date: September 15, 2020

Quantum Interventional Endocrinology Course Objective:

  1. Learn and understand the evidence-based theory of Interventional Endocrinology and the science behind and clinical applications of hormone therapy for patients who have been property assessed and diagnosed as deficient.

SPECIAL OFFER

Save 35%

This course is part of the Hormone Use in Clinical Age Management Medicine bundle.
Purchase the complete series and save!

COURSE MENU

ACCOUNT MENU

NEED HELP?

FACULTY

Bauman, Alan J. - M.D., ABHRS
  • Founder & Medical Director, Bauman Medical Group, Boca Raton, FL

Alan J. Bauman, M.D.

Alan J. Bauman, M.D. is a full-time board-certified hair restoration physician who has treated over 17,000 patients and performed over 8,000 hair transplant procedures since starting his medical hair loss practice, Bauman Medical in 1997. Currently located in Boca Raton, Florida, Dr. Bauman received his M.D. degree from New York Medical College and surgical residency training at Mt. Sinai Medical Center and Beth Israel Medical Center in New York. Dr. Bauman is one of approximately only 200 physicians worldwide to achieve the certification from the esteemed American and International Board of Hair Restoration Surgery (ABHRS), is an accepted member of the International Alliance of Hair Restoration Surgeons (IAHRS), and is also recommended by the American Hair Loss Association. Dr. Bauman has achieved the coveted Fellow status within the International Society of Hair Restoration Surgery (ISHRS) and is a frequently invited faculty member at numerous international scientific meetings and live surgery workshops.

Faculty Disclosure: Dr. Bauman reported he has no relevant financial interests

Buy this Course